The ongoing search for long COVID treatments
26 April 2023
Food and Drug Administration officials are turning to patients who've experimented with unproven treatments for clues about how to manage the condition and design clinical trials. Government efforts have so far yielded little for the more than 20 million Americans experiencing ongoing symptoms, with questions particularly swirling around a $1 billion National Institutes of Health effort called RECOVER. Patients told FDA officials about ... efforts to treat symptoms with old drugs and supplements, most of which aren't covered by insurance because of the off-label use. The list included low-dose naltrexone to alleviate inflammation.